作者
N Fleeman, C Martin Saborido, K Payne, A Boland, R Dickson, Y Dundar, A Fernández Santander, S Howell, W Newman, J Oyee, T Walley
发表日期
2011
来源
NIHR Health Technology Assessment programme: Executive Summaries
出版商
NIHR Journals Library
简介
Background
Breast cancer is the most common cancer affecting women in the UK. Tamoxifen (TAM) is considered the standard of care for premenopausal women with oestrogen receptor positive (ER+) breast cancer and for postmenopausal women with ER+ early breast cancer considered to be at low risk of disease recurrence.
学术搜索中的文章
N Fleeman, CM Saborido, K Payne, A Boland… - NIHR Health Technology Assessment programme …, 2011